Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2005-07-12
2005-07-12
Saoud, Christine J. (Department: 1647)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S399000, C435S069400, C435S069700, C435S243000
Reexamination Certificate
active
06916786
ABSTRACT:
This invention relates to newly identified polynucleotides, polypeptides encoded by such polynucleotides, the use of such polynucleotides and polypeptides, as well as the production of such polynucleotides and polypeptides. More particularly, the polypeptide of the present invention is a Keratinocyte Growth Factor, sometimes hereinafter referred to as “KGF-2” also formerly known as Fibroblast Growth Factor 12 (FGF-12). This invention further relates to the therapeutic use of KGF-2 to promote or accelerate wound healing. This invention also relates to novel mutant forms of KGF-2 that show enhanced activity, increased stability, higher yield or better solubility.
REFERENCES:
patent: 5194596 (1993-03-01), Tischer et al.
patent: 5350836 (1994-09-01), Kopchick et al.
patent: 5580856 (1996-12-01), Prestrelski et al.
patent: 5677278 (1997-10-01), Gospodarowicz et al.
patent: 5703047 (1997-12-01), Wilson
patent: 5731170 (1998-03-01), Rubin et al.
patent: 5773252 (1998-06-01), Greene et al.
patent: 5773586 (1998-06-01), Gospodarowicz et al.
patent: 5814605 (1998-09-01), Pierce et al.
patent: 5824643 (1998-10-01), Pierce et al.
patent: 5843883 (1998-12-01), Gospodarowicz et al.
patent: 5863767 (1999-01-01), Gospodarowicz et al.
patent: 6077692 (2000-06-01), Ruben et al.
patent: 6238888 (2001-05-01), Gentz et al.
patent: 0 619 370 (1994-10-01), None
patent: 2 321 852 (1998-08-01), None
patent: 7-345689 (1995-12-01), None
patent: 8-103240 (1996-03-01), None
patent: 8-214378 (1996-07-01), None
patent: 10-330283 (1998-12-01), None
patent: 10-330284 (1998-12-01), None
patent: 10-330285 (1998-12-01), None
patent: WO 90/08771 (1990-08-01), None
patent: WO 92/14480 (1992-09-01), None
patent: WO 92/22304 (1992-12-01), None
patent: WO 93/21908 (1993-11-01), None
patent: WO 94/22427 (1994-10-01), None
patent: WO 94/23032 (1994-10-01), None
patent: WO 95/01434 (1995-01-01), None
patent: WO 95/03831 (1995-02-01), None
patent: WO 95/24928 (1995-09-01), None
patent: WO 95/24928 (1995-10-01), None
patent: WO 96/11949 (1996-04-01), None
patent: WO 96/11950 (1996-04-01), None
patent: WO 96/11951 (1996-04-01), None
patent: WO 96/11952 (1996-04-01), None
patent: WO 96/22369 (1996-07-01), None
patent: WO 96/25422 (1996-08-01), None
patent: WO 97/20929 (1997-12-01), None
patent: WO 98/06844 (1998-02-01), None
patent: WO 98/16243 (1998-04-01), None
patent: WO 98/16642 (1998-04-01), None
patent: WO 99/32155 (1999-07-01), None
patent: WO 99/41282 (1999-08-01), None
patent: WO 00/72872 (2000-12-01), None
patent: WO 01/02433 (2001-01-01), None
Bowie, J.U. et al., “Deciphering the Message in Protein Sequences: Tolerance to Amino Acid Substitutions,”Science 247:1306-1310, American Association for the Advancement of Science (1990).
Finch, P. W. et al., “Human KGF Is FGF-Related with Properties of a Paracrine Effector of Epithelial Cell Growth,”Science 245:752-755, American Association for the Advancement of Science (1989).
Hartung, H. et al., “Murine FGF-12 and FGF-13: expression in embryonic nervous sytem, connective tissue and heart,”Mech. Develop. 64:31-39 Elsevier Science Ireland Ltd. (Jun. 1997).
Hartung, H. et al., “Assignment ofFgf12to mouse chromosome bands 1681→B3 in situ hybridization,”Cytogenet. Cell Genet. 76:185-186 Karger A.G. (Apr. 1997).
Jimenez, P. et al., “Effect of Topical Keratinocyte Growth Factor-2 on Wound Healing In A Glucocorticoid-Impaired Model,”J. Cutan Pathol. 24:105, The American Society of Dermatopathology, Munksgaard (Feb. 1997).
Jimenez, P.A. et al., “Effect of Keratinocyte Growth Factor-2 on Cell Proliferation In Vivo,”FASEB J. 11:A523, Abstract No. 3025, Federation of American Societies for Experimental Biology (Apr. 1997).
Jimenez, P.A. and Rampy, M.A., “Keratinocyte Growth Factor-2 Accelerates Wound Healing in Incisional Wounds,”J. Surg. Res. 81:238-242, Academic Press, Inc. (Feb. 1999).
Kelley, M. J. et al., “Emergence of the keratinocyte growth factor multigene family during the great ape radiation,”Proc. Natl. Acad. USA 89:9287-9291, National Academy of Sciences of the USA (1992).
Mason, I. J. et al., “FGF-7 (keratinocyte growth factor) expression during mouse development suggests roles in myogenesis, forebrain regionalisation and epithelial-mesenchymal interactions,”Mech. Dev. 45:15-30, Elsevier Science Ireland Ltd. (Jan. 1994).
Miyamoto, M. et al., “Molecular Cloning of a Novel Cytokine cDNA Encoding the Ninth Member of the Fibroblast Growth Factor Family, Which Has a Unique Secretion Property,”Mol. Cell. Biol. 13(7):4251-4259, American Society for Microbiology (1993).
Ngo, J.T. et al., “Computational Complexity, Protein Structure Prediction, and the Levinthal Paradox,” in:The Protein Folding Problem and Tertiary Structure Prediction,Merz, Jr., K. and Le Grand, S., eds., Birkhauser, Boston, Massachusetts, pp. 491-495 (1994).
Robson, B. and Garnier, J., “Modern ideas and notations relating to primary structure,” in:Introduction to Protein Engineering,Robson, B. and Gernier, J., eds., Elsevier Science, Amsterdam, The Netherlands, p. 41 (1986).
Ron, D. et al., “Expression of Biologically Active Recombinant Keratinocyte Growth Factor,”J. Biol. Chem. 268(4):2984-2988 American Society for Biochemistry and Molecular Biology, Inc. (1993).
Wells, J.A., “Additivity of Mutational Effects in Proteins,”Biochemistry 29:8509-8517, American Chemical Society (1990).
Yamasaki, M. et al., “Structure and Expression of the Rat mRNA Encoding a Novel Member of the Fibrolast Growth Factor Family,”J. Biol. Chem. 271:15918-15921, The American Society for Biochemistry and Molecular Biology, Inc. (Jul. 1996).
Yan, G. et al., “Sequence of Rat Keratinocyte Growth Factor (Heparin-Binding Growth Factor Type 7),”In Vitro Cell. Dev. Biol. 27A:437-438, Tissue Culture Association (1991).
NCBI Entrez, GenBank Report with Revision History, Accession No. M79878, McCombie, W.R. et al. (1992).
NCBI Entrez, GenBank Report with Revision History, Accession No. T52063, Hillier, L. et al. (Feb. 1995).
NCBI Entrez, GenBank Report with Revision History, Accession No. D46201, Sasaki, T. et al. (Aug. 1995).
NCBI Entrez, GenBank Report with Revision History, Accession No. D46420, Sasaki, T. et al. (Aug. 1995).
NCBI Entrez, GenBank Report with Revision History, Accession No. D54216, Fujiwara, T. et al. (Sep. 1995).
NCBI Entrez, GenBank Report with Revision History, Accession No. D68729, Kohara, Y. et al. (Dec. 1995).
NCBI Entrez, GenBank Report with Revision History, Accession No. D69248, Kohara, Y. et al. (Dec. 1995).
NCBI Entrez, GenBank Report with Revision History, Accession No. D65627, Kohara, Y. et al. (Dec. 1995).
NCBI Entrez, GenBank Report with Revision History, Accession No. D66221, Kohara, Y. et al. (Dec. 1995).
NCBI Entrez, GenBank Report with Revision History, Accession No. C02000, Okubo, K. (Jul. 1996).
NCBI Entrez, GenBank Report with Revision History, Accession No. W29377, Marra, M. et al. (Sep. 1996).
NCBI Entrez, GenBank Report with Revision History, Accession No. W32720, Hillier, L. et al. (Oct. 1996).
NCBI Entrez, GenBank Report with Revision History, Accession No. W60824, Hillier, L. et al. (Oct. 1996).
NCBI Entrez, GenBank Report with Revision History, Accession No. T70682, Shen, B. et al. (Oct. 1996).
NCBI Entrez, GenBank Report with Revision History, Accession No. AA094753, Liew, C.C. (Oct. 1996).
NCBI Entrez, GenBank Report with Revision History, Accession No. AA133331, Hillier, L. et al. (Nov. 1996).
NCBI Entrez, GenBank Report with Revision History, Accession No. AA190058, Marra, M. et al. (Jan. 1997).
NCBI Entrez, GenBank Report with Revision History, Accession No. AA018953, Hillier, L. et al. (Jan. 1997).
NCBI Entrez, GenBank Report with Revision History, Accession No. AA240978, Marra, M. et al. (Mar. 1997).
NCBI Entrez, GenBank Report with Revision History, Accession No. AA289560, Marra, M. et al. (Apr. 1997).
NCBI Entrez, GenBank Report with Revision His
Coleman Timothy A.
Dillon Patrick J.
Duan D. Roxanne
Gentz Reiner L.
Gruber Joachim R.
Human Genome Sciences Inc.
Human Genome Sciences Inc.
Saoud Christine J.
LandOfFree
Keratinocyte growth factor-2 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Keratinocyte growth factor-2, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Keratinocyte growth factor-2 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3377637